Eruptive pseudoangiomatosis: An outbreak in the third wave of COVID-19

A range of skin manifestations has been reported since the beginning of the COVID-19 pandemic. These findings earlier thought to be due to direct cytopathic effects of the virus are now predominantly known to be paraviral eruptions due to an immune reaction to the virus. Eruptive pseudoangiomatosis is one such paraviral eruption which has been scarcely reported to be associated with COVID-19 vaccination or infection. We did not find any such association during the first two waves of COVID; however, we found a phenomenal increase in cases of eruptive pseudoangiomatosis with the third wave of COVID-19 in India which coincided with the spread of the Omicron variant. Hereby, we report a case series of ten such cases. All these cases had a temporal correlation with COVID-19 infection and resolved spontaneously without recurrence within 14 days.